DOJ's Evolving Enforcement Approach to Off-Label Promotion | Skadden, Arps, Slate, Meagher & Flom LLP
Enforcement in Life Sciences Series: Key Cases in 2020 Reflect Emerging DOJ Focus for Pharmaceutical and Medical Device Makers About the Enforcement in Life Sciences Series Recent settlements between the U.S. Department of Justice (DOJ) and a range of FDA-regulated drug and medical device manufacturers provide a snapshot of the DOJ’s enforcement focus. These settlements involve new DOJ theories of liability or new ways of evaluating long-standing industry practices, and may be harbingers of f...
Avanir Pharmaceuticals Enforcement In Life Sciences Series Pharmaceuticals To Pay Office Of Public Affairs Meagher Flom Edusa Pharmaceuticals
Source: jdsupra.com